Clin2
NCT07069894Likely a fitNot yet recruiting

Herbal injection for sepsis patients in the hospital

Sepsis

Part of Infections clinical trials.

This trial tests a Chinese herbal medicine called Xuebijing, given as an injection, to see if it helps people with sepsis recover better. It is being studied in real-world hospital settings to understand how well it works outside of strict research conditions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5,400 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Be 18 years or older and currently in the hospital
  • Have been diagnosed with sepsis within the last 48 hours
  • Have not had sepsis before this time
  • Not be taking part in any other clinical trial
  • Agree to participate, either yourself or through a legal representative

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06514339Recruiting· Early Phase 1
Shenhuang granules for sepsis treatment

This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.

Hangzhou, Zhejiang
NCT07066553Not yet recruiting
Tracking sepsis outcomes in Chinese hospitals

This study collects information from adult patients hospitalized with sepsis to better understand how sepsis affects people in China. By joining, you'll help researchers learn more about this condition to improve future care.

Nanjing, Jiangsu
NCT06915506Not yet recruiting· Phase 4
Shenfu injection for blood vessel health in sepsis

This study tests whether a traditional Chinese medicine called Shenfu injection can improve the flexibility of the carotid artery in people with sepsis or septic shock. It may help doctors understand if this treatment can reduce complications from severe infections.

Wuhu, Anhui
NCT06920420Not yet recruiting
Xuebijing injection for improving sepsis outcomes

This trial tests whether a herbal injection called Xuebijing, plus standard care, can improve recovery from sepsis. It aims to find new markers in the blood that may help predict how well the treatment works.

NCT07599644Recruiting
Sepsis Risk Study in Chinese ICU Patients

This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.

Shaoguan, Guangdong
NCT06344819Recruiting· Phase 2
Acupuncture for People at High Risk of Sepsis

This study tests whether acupuncture can help people at high risk for sepsis, a serious infection that can lead to organ failure. If you’re 18 or older, have had a sepsis order set put in within the last two days, and are not yet in the ICU, you may be able to join.

Irvine, California

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.